GlassScriptPhysician profile
Rajesh Gupta
NPI 1164680674
$15,563.74
in general payments reported to CMS, 2019-2025
60 companies · $2,236 in 2025
The $2,236 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,300 · 2020: $1,339 · 2021: $1,873 · 2022: $2,429 · 2023: $1,337 · 2024: $4,049 · 2025: $2,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,975 · Travel and Lodging: $1,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,974.58 |
| Travel and Lodging | $1,648.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $2,618.43 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Livanova USA, INC. | $1,976.30 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $1,435.23 | 2021-2025 | |
| Sk Life Science, INC. | $795.85 | 2021-2025 | Xcopri |
| Supernus Pharmaceuticals, INC. | $720.74 | 2019-2023 | Qelbree |
| Neuropace, INC. | $619.74 | 2019-2025 | |
| Lilly USA, LLC | $600.81 | 2019-2025 | Amyvid, Kisunla, Reyvow |
| Novartis Pharmaceuticals Corporation | $570.86 | 2019-2025 | |
| Eisai INC. | $405.75 | 2022-2025 | |
| Allergan, INC. | $395.59 | 2019-2022 | |
| Lundbeck LLC | $376.22 | 2019-2023 | Vyepti |
| Jazz Pharmaceuticals INC. | $302.75 | 2019-2025 | |
| Medtronic, INC. | $299.28 | 2022-2025 | Percept PC Brainsense |
| Biogen, INC. | $298.49 | 2019-2025 | Leqembi, Spinraza |
| Neurelis, INC. | $286.63 | 2021-2025 | Valtoco |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.